Form 4 Tracker
Peter Heerma

CHIEF COMMERCIAL OFFICER; EVP, CHIEF COMMERCIAL OFFICER · 4 filings · Latest: Sep 15, 2026

Travere Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TVTX
Peter HeermaEVP, CHIEF COMMERCIAL OFFICERSep 17, 2026
Sale
$65.078,282$538.9K117,066
TVTX
Peter HeermaEVP, CHIEF COMMERCIAL OFFICERSep 17, 2026
Option Exercise
$22.408,282$185.5K125,348
TVTX
Peter HeermaEVP, CHIEF COMMERCIAL OFFICERSep 16, 2026
Sale
$63.43172,717$11.0M117,066
TVTX
Peter HeermaEVP, CHIEF COMMERCIAL OFFICERSep 16, 2026
Option Exercise
$14.19172,717$2.5M289,783
TVTX
Peter HeermaEVP, CHIEF COMMERCIAL OFFICERSep 15, 2026
Sale
$62.26102,190$6.4M117,066
TVTX
Peter HeermaEVP, CHIEF COMMERCIAL OFFICERSep 15, 2026
Option Exercise
$18.3177,190$1.4M219,256
TVTX
PETER HEERMA—Sep 17, 2026
Proposed Sale
$63.488,282$525.7K—
TVTX
PETER HEERMA—Sep 16, 2026
Proposed Sale
$62.51172,717$10.8M—
TVTX
PETER HEERMA—Sep 15, 2026
Proposed Sale
$65.79102,190$6.7M—
TVTX
Peter HeermaCHIEF COMMERCIAL OFFICERMay 5, 2026
Sale
$46.652,174$101.4K140,684
TVTX
Peter HeermaCHIEF COMMERCIAL OFFICERMay 4, 2026
Option Exercise
$0.004,250—142,858
TVTX
Peter Heerma—May 5, 2026
Proposed Sale
$46.652,174$101.4K—
TVTX
Peter HeermaCHIEF COMMERCIAL OFFICERApr 14, 2026
Sale
$41.937,215$302.5K138,608
TVTX
Peter Heerma—Apr 14, 2026
Proposed Sale
$41.937,215$302.5K—
TVTX
Peter Heerma—Feb 3, 2026
Proposed Sale
$32.127,310$234.8K—
TVTX
Peter HeermaCHIEF COMMERCIAL OFFICERFeb 3, 2026
Sale
$32.127,310$234.8K131,823
TVTX
Heerma Peter—Dec 24, 2025
Proposed Sale
$40.004,980$199.2K—
TVTX
Heerma Peter—Oct 31, 2025
Proposed Sale
$35.005,591$195.7K—
TVTX
Heerma Peter—Oct 28, 2025
Proposed Sale
$30.002,662$79.9K—
TVTX
Peter Heerma—May 5, 2025
Proposed Sale
$21.051,771$37.3K—

Page 1 of 2

Next →